Claps Industries Pvt. Ltd.

Country/Region: India     State/Province: Delhi

Main Products: Around 15 Segments Including Antibiotic, Prefilled Syringes & Neutraceuticals, Cosmoceuticals

Company Introduction
Dear Sir/Madam, Warm greetings from CLAPS Industries Pvt. Ltd., INDIA!I would like to take this opportunity of briefly introducing CLAPS INDUSTRIES PVT. LTD., which is a rapidly growing organization, a well-established and business transactions being carried out in Russia, CIS Countries, Latin America, Asia Pacific and African countries with best quality & competitive price. Our manufacturing process internationally recognized & approved by WHO GMP, USFDA, PPB-Kenya, and a lot of African drug authorities. We boast a thorough knowledge and expertise in their respective therapeutic segments. Today CLAPS has more than 600 pharmaceutical products with varied segments, such as Oncology Cardiac Critical care Antibiotic Anticoagulants Antacid Immunosuppressive CNS Hormones Anaesthetic NSAIDS Hypothyroid Nutraceuticals Blood Product HIV Skeletal Muscle Relaxant Dermatology Antiemetic Anti-Diarrhoeal Antidiabetics Steroids Antiplatelet Agent Antifungal Antihistamine HerbalsHence, our focus is on the critical care segment with Antibiotic, Prefilled Syringes & Neutraceuticals, Cosmoceuticals research based drugs.We look forward to building enjoyable and long-term business relationship which benefits both the companies in future.Please do not hesitate to contact me if you need any further information. With best regards, Deepak Kumar SinghExecutive International Regulatory Affairs & Business Development CLAPS Industries Pvt. Ltd.B-1202, Infinity Tower, Beside Hotel Ramada60 Feet Road, Prahalad NagarAhmedabad
Company Overview

Business Type: Wholesaler, Trader

Year Established: 2001

Employees: 101 - 200 People

Plant Area: 10,000-30,000 square meters

Business Information

Main Markets: South America 8% Africa 8% Eastern Asia 8% Domestic Market 9% North America 11% Eastern Europe 12% Southern Europe 8% Mid East 12% Northern Europe 12% Oceania 12%

Trade Capacity: FOB, CIP, DAF

Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered

Nearest Port: GUJARAT, INDIA

Trade & Financial Information

Annual Revenue: Above US$100 Million

Total Revenue: US$10 Million - US$50 Million

Export Revenue: confidential

Annual Output: US$5 Million - US$10 Million

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 31% - 40%

Payment Modes: USD, CAD, CNY

Lead Time: 15 days

Import/Export Mode: Using an agent

Product Showcase
Around 15 Segments including Antibiotic
Prefilled Syringes & Neutraceuticals
Cosmoceuticals

CL-Link > Health & Medicines in India Health & Medicines in Delhi Medical Consumable in India Medical Consumable in Delhi Syringes in India Syringes in Delhi